154 related articles for article (PubMed ID: 7715897)
21. Radioimmunoguided surgery of colorectal carcinoma with an 111In-labelled anti-TAG72 monoclonal antibody.
Muxi A; Pons F; Vidal-Sicart S; Setoain FJ; Herranz R; Novell F; Fernandez RM; Trias M; Setoain J
Nucl Med Commun; 1999 Feb; 20(2):123-30. PubMed ID: 10088160
[TBL] [Abstract][Full Text] [Related]
22. Improved detection of hepatic lesions using MoAb B72.3 and a modified 111In labelling technique in patients with recurrent colon cancer.
Vijayakumar V; Blend MJ; Johnson DK; Seevers RH; Schnobrich KE; Bekerman C
Nucl Med Commun; 1993 Aug; 14(8):658-66. PubMed ID: 8371891
[TBL] [Abstract][Full Text] [Related]
23. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N
Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095
[TBL] [Abstract][Full Text] [Related]
24. Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer. Correlation with computed tomography, surgery, histopathology, immunohistology, and human immune response.
Winzelberg GG; Grossman SJ; Rizk S; Joyce JM; Hill JB; Atkinson DP; Sudina K; Anderson K; McElwain D; Jones AM
Cancer; 1992 Apr; 69(7):1656-63. PubMed ID: 1551051
[TBL] [Abstract][Full Text] [Related]
25. Detection of hepatic metastases from colorectal carcinoma using indium-111 (111In) labeled monoclonal antibody (mAb): MSKCC experience with mAb 111In-C110.
Divgi CR; McDermott K; Johnson DK; Schnobrich KE; Finn RD; Cohen AM; Larson SM
Int J Rad Appl Instrum B; 1991; 18(7):705-10. PubMed ID: 1787079
[TBL] [Abstract][Full Text] [Related]
26. Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody.
Mirallié E; Saï-Maurel C; Faivre-Chauvet A; Regenet N; Chang CH; Goldenberg DM; Chatal JF; Barbet J; Thedrez P
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):901-9. PubMed ID: 15864584
[TBL] [Abstract][Full Text] [Related]
27. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
[TBL] [Abstract][Full Text] [Related]
28. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
29. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
Chetanneau A; Baum RP; Lehur PA; Liehn JC; Perkins AC; Bares R; Bourguet P; Herry JY; Saccavini JC; Chatal JF
Eur J Nucl Med; 1990; 17(5):223-9. PubMed ID: 2083556
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of 99mTc-anti-CEA immunoscintigraphy in patients with liver metastases from colorectal carcinoma.
Bock E; Becker W; Scheele J; Wolf F
Nuklearmedizin; 1992 Jun; 31(3):80-3. PubMed ID: 1641359
[TBL] [Abstract][Full Text] [Related]
31. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
[TBL] [Abstract][Full Text] [Related]
32. The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.
Davidson BR; Babich J; Young H; Waddington W; Clarke G; Short M; Boulos P; Styles J; Dean C
Br J Cancer; 1991 Nov; 64(5):850-6. PubMed ID: 1931605
[TBL] [Abstract][Full Text] [Related]
33. Immunoscintigraphy of colorectal carcinomas with radiolabeled monoclonal antibody fragments.
Obradovic V; Artiko V; Petrovic M; Stefanovic B; Krivokapic Z; Zuvela M; Stojkovic M; Stefanovic B; Milovanovic A; Vlajkovic M
Hepatogastroenterology; 2006; 53(70):526-30. PubMed ID: 16995454
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
[TBL] [Abstract][Full Text] [Related]
35. Immunoscintigraphy with a new indium-111-labeled monoclonal antibody (MAb 1A3) in patients with colorectal cancer.
Philpott GW; Siegel BA; Schwarz SW; Connett JM; Rocque PA; Fleshman JW; Wallis JW; Baumann M; Sun Y; Martell AE
Dis Colon Rectum; 1994 Aug; 37(8):782-92. PubMed ID: 8055723
[TBL] [Abstract][Full Text] [Related]
36. Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.
Le Doussal JM; Gruaz-Guyon A; Martin M; Gautherot E; Delaage M; Barbet J
Cancer Res; 1990 Jun; 50(11):3445-52. PubMed ID: 2334941
[TBL] [Abstract][Full Text] [Related]
37. Radioimmunoscintigraphy of colorectal carcinoma with a 99Tcm-labelled anti-CEA monoclonal antibody (BW 431/26).
Muxí A; Solá M; Bassa P; Pons F; García A; Moragas M; Lomeña F; Herranz R; Fernández R; Trias M
Nucl Med Commun; 1992 Apr; 13(4):261-70. PubMed ID: 1589179
[TBL] [Abstract][Full Text] [Related]
38. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
Paganelli G; Magnani P; Zito F; Villa E; Sudati F; Lopalco L; Rossetti C; Malcovati M; Chiolerio F; Seccamani E
Cancer Res; 1991 Nov; 51(21):5960-6. PubMed ID: 1933860
[TBL] [Abstract][Full Text] [Related]
39. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?
Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F
Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871
[TBL] [Abstract][Full Text] [Related]
40. Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Bohdiewicz PJ; Scott GC; Juni JE; Fink-Bennett D; Wilner F; Nagle C; Dworkin HJ
Clin Nucl Med; 1995 Mar; 20(3):230-6. PubMed ID: 7750217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
